Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanya Nadia Glatt

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Research Square|February 17, 2021
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021Wendy Sykes, Laurette Mhlanga, Ronel Swanevelder, et al.
Vox Sanguinis|December 29, 2023
The evolution and interpretation of seroprevalence of SARS-CoV-2 antibodies among South African blood donors from the Beta to Omicron variant-driven wavesMarion Vermeulen, Laurette Mhlanga, Wendy Sykes, et al.
Journal of Clinical Apheresis|December 1, 2025
Real-World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis SystemAaron Haubner, Sebastian Mendoza, Hans Vrielink, et al.
Research Square|June 6, 2022
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022Jeremy Bingham, Russel Cable, Charl Coleman, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 5, 2026
The safety and cost of Gelofusine as a replacement fluid in therapeutic plasma exchange procedures - Feedback from low/middle-income countriesTanya Nadia Glatt, Thabo Gcayiya, Yona Skosana, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 5, 2026
Status of donor and clinical apheresis across the African continent: A report of a 2025 surveyTanya Nadia Glatt, Thabo Gcayiya, Willem van der Merwe, et al.
Viruses|October 26, 2021
Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme-The South African ExperienceTanya Nadia Glatt, Caroline Hilton, Cynthia Nyoni, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 18, 2025
The number of apheresis procedures to treat immune-mediated neurological diseases is on the riseKaatje Le Poole, Hans Vrielink, Astrid Aandahl, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 6, 2025
Update of data from the world apheresis association (WAA) registryBernd Stegmayr, Hans Vrielink, Volker Witt, et al.
Scientific Reports|February 16, 2022
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)Karin van den Berg, Tanya Nadia Glatt, Marion Vermeulen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Research Square|February 17, 2021
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021Wendy Sykes, Laurette Mhlanga, Ronel Swanevelder, et al.
Vox Sanguinis|December 29, 2023
The evolution and interpretation of seroprevalence of SARS-CoV-2 antibodies among South African blood donors from the Beta to Omicron variant-driven wavesMarion Vermeulen, Laurette Mhlanga, Wendy Sykes, et al.
Journal of Clinical Apheresis|December 1, 2025
Real-World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis SystemAaron Haubner, Sebastian Mendoza, Hans Vrielink, et al.
Research Square|June 6, 2022
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022Jeremy Bingham, Russel Cable, Charl Coleman, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 5, 2026
The safety and cost of Gelofusine as a replacement fluid in therapeutic plasma exchange procedures - Feedback from low/middle-income countriesTanya Nadia Glatt, Thabo Gcayiya, Yona Skosana, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 5, 2026
Status of donor and clinical apheresis across the African continent: A report of a 2025 surveyTanya Nadia Glatt, Thabo Gcayiya, Willem van der Merwe, et al.
Viruses|October 26, 2021
Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme-The South African ExperienceTanya Nadia Glatt, Caroline Hilton, Cynthia Nyoni, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 18, 2025
The number of apheresis procedures to treat immune-mediated neurological diseases is on the riseKaatje Le Poole, Hans Vrielink, Astrid Aandahl, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 6, 2025
Update of data from the world apheresis association (WAA) registryBernd Stegmayr, Hans Vrielink, Volker Witt, et al.
Scientific Reports|February 16, 2022
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)Karin van den Berg, Tanya Nadia Glatt, Marion Vermeulen, et al.
Pageof 1